Molecular Biomarkers and Imaging Markers in the Prediction, Diagnosis, and Prognosis of Bladder Cancer

75.7K

views

154

authors

19

articles

Editorial

14 October 2022

Editorial: Molecular biomarkers and imaging markers in the prediction, diagnosis, and prognosis of bladder cancer

Yongwen Luo

,

Fang-Ming Deng

,

Yi Zhang

and

Yu Xiao

1,975 views

1 citations

Editors

4

Zhongnan Hospital, Wuhan University

Euler Technology

Zhongnan Hospital, Wuhan University

Langone Medical Center, New York University

Impact

About

Bladder cancer is one of most common malignant cancers worldwide and has the highest recurrence rate of any solid tumor. Currently the major treatment of bladder cancer is surgery and chemotherapy. The therapeutic effect is still not satisfactory, Patients who underwent radical cystectomy had a 5-year overall survival rate of 66% and a 10-year survival rate of 43%, and there is still a lack of public recognized, universally applicable bladder cancer diagnosis and prognostic evaluation markers.
Biomarkers are tools used to more accurately identify high-risk individuals, to speed the diagnosis, and to help in treatment and prognosis determination. Biomarkers can be classified based on different parameters, including their characteristics, such as imaging biomarkers (echocardiography, computed tomography, magnetic resonance imaging) or molecular biomarkers.
The goal of this Special Issue is to summarize new advances in both molecular and imaging biomarkers of bladder cancer, especially in risk prediction, screening, diagnosis, and prognosis. Original research and review articles are both welcome in order to best understand the importance of different biomarkers in bladder cancer.
Potential topics include but are not limited to the following:
• Advances in molecular biomarkers and bladder cancer
• Advances in imaging biomarkers and bladder cancer
• The synergy of molecular and imaging biomarkers in predicting and detecting bladder cancer
• The synergy of molecular and imaging biomarkers in the assessment of prognosis in bladder cancer
• Biomarkers for the evaluation of drug resistance in bladder cancer

Bladder cancer is one of most common malignant cancers worldwide and has the highest recurrence rate of any solid tumor. Currently the major treatment of bladder cancer is surgery and chemotherapy. The therapeutic effect is still not satisfactory, Patients who underwent radical cystectomy had a 5-year overall survival rate of 66% and a 10-year survival rate of 43%, and there is still a lack of public recognized, universally applicable bladder cancer diagnosis and prognostic evaluation markers.
Biomarkers are tools used to more accurately identify high-risk individuals, to speed the diagnosis, and to help in treatment and prognosis determination. Biomarkers can be classified based on different parameters, including their characteristics, such as imaging biomarkers (echocardiography, computed tomography, magnetic resonance imaging) or molecular biomarkers.
The goal of this Special Issue is to summarize new advances in both molecular and imaging biomarkers of bladder cancer, especially in risk prediction, screening, diagnosis, and prognosis. Original research and review articles are both welcome in order to best understand the importance of different biomarkers in bladder cancer.
Potential topics include but are not limited to the following:
• Advances in molecular biomarkers and bladder cancer
• Advances in imaging biomarkers and bladder cancer
• The synergy of molecular and imaging biomarkers in predicting and detecting bladder cancer
• The synergy of molecular and imaging biomarkers in the assessment of prognosis in bladder cancer
• Biomarkers for the evaluation of drug resistance in bladder cancer

Download ebook

Share

Editors

Zhongnan Hospital, Wuhan University

Euler Technology

Zhongnan Hospital, Wuhan University

Langone Medical Center, New York University

Impact

75,730 Total views

45,390 Article views

28,582 Article downloads

1,758 Topic views

Published In

Journal Thumbnail

Frontiers in Cell and Developmental Biology

Molecular and Cellular Pathology

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Suggest a topic